CUTANEOUS LUPUS ERYTHEMATOSUS
Clinical trials for CUTANEOUS LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stubborn lupus skin rash: drug trial underway
Disease control OngoingThis study tests a drug called anifrolumab for people with lupus-related skin rashes that haven't improved with standard treatments. About 306 adults will receive either the drug or a placebo to see if it reduces rash severity by 70%. The goal is to control the disease, not cure …
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
Could a psoriasis drug tame lupus skin flares?
Symptom relief ENROLLING_BY_INVITATIONThis early study tests whether a cream called Tapinarof, already approved for psoriasis, can improve skin rashes caused by lupus. Ten adults with chronic or subacute cutaneous lupus will apply the cream for 16 weeks. Researchers will measure rash changes and study skin and blood …
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated May 17, 2026 06:44 UTC